Alternatives to MindImmune

Global supplier of life science research tools, including antibodies, reagents, and assays.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Developing novel immunotherapies and diagnostics for cancer.

AI-powered precision testing for patient identification in clinics and clinical trials.

Revolutionizing genomic analysis with innovative sequencing technology.

Develops nanostructured sensor chips for rapid pathogen identification in food.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.

Wearable chip that analyzes proteins and hormones in real time.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Developing breath-based diagnostics for lung diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing an automated platform for liquid biopsy sample preparation.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Biopharmaceutical company developing and commercializing CNS disease treatments.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Enzyme-based technology to break down alcohol in the stomach.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A vertically-integrated procurement platform for the life sciences industry.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

A leading organization dedicated to curing and treating cystic fibrosis.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Accelerating patient access to evidence-based innovation in mental health.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

A biotechnology company developing genetic therapies for rare disorders.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Developing gene editing therapies to lower cholesterol.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

AI-driven biotech company engineering novel proteins for therapeutics and sustainability.

AI-powered knowledge discovery for life sciences.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

A venture capital firm that operates multiple accelerators and invests in startups globally.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.